European Society of Toxicology In Vitro > Uncategorized > ESTIV welcomes two new corporate members!
26 July 2021

ESTIV welcomes two new corporate members!

React4life is an Italian startup that developed MIVO® – Multi In Vitro Organ, a patented microphysiological system (MPS) able to reproduce portions of the human body improving the reliability of the testing outcome. It can easily accommodate and cultivate 3D human tissues, organoids or biopsies to suit every testing needs. MIVO® can be used as bioreactor, for enhancing tissues conditions and prolonging lifetime, for advanced drug testing assays on 3D tissues, for discovering new therapeutic approaches, and for basic research, without involving animal use. It is individually blistered, sterile, disposable, immediately ready-to-use.For more information visit:
www.react4life.com
Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food. Its sales of € 3.5 billion in the 2020 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. In addition, Symrise has set up an animal testing policy in 2009 that aims to minimize such testing and Symrise is promoting alternative approaches wherever possible.


For more information visit:
www.symrise.com

Related content

ESTIV – ASCCT Award Winners Series: Madison Feshuk, Bhaja Padhi, and Rachel Broughton

We hope you will join us on March 11, 2025, for the next installment of our 2025 Award Winners Webinar Series…

Freelance Editor-in-Chief — Contract for Services

  • News

A freelance contract opportunity has arisen for an experienced Editor-in-Chief to join the existing ATLA team of Managing Editor, Technical Editor and Associate Editors for an initial period of three years, including a six-month trial.

PAROPEDIA NEWSLETTER #4 – EDITORIAL BY ESTIV PRESIDENT DR.HELENA KANDAROVA

  • News

The latest editorial for PARCOpedia by ESTIV President Dr. Helena Kandarova highlights the crucial role of collaborative platforms like PARCopedia in advancing Next-Generation Risk Assessment (NGRA) and New Approach Methodologies (NAMs).

Silver Sponsor

Memorandum of Understanding